AB SCIEX has been launched as a new company dedicated to life science analytical technologies. The new company is formed from the combination of the two halves of the AB SCIEX mass spectrometry joint venture.
AB SCIEX has been launched as a new company dedicated to life science analytical technologies. The new company is formed from the combination of the two halves of the AB SCIEX mass spectrometry joint venture.
“This integrated company will be able to shape the future of mass spectrometry in ways far greater than what we have already achieved,” said Laura Lauman, the company’s president, in a statement. According to Lauman, bringing the former joint venture together will enable the company to “keep pace with the dynamic needs of the life science industry.”
The company provides instrumentation, software and services used in a number of life science applications, including drug discovery and development, disease studies and food and environmental safety. These include integrated LC–MS–MS platforms for small molecule analysis, contaminant identification and biomarker validation, as well as MALDI TOF/TOF systems for protein biomarker discovery.
For more information about the company go to www.absciex.com
Best of the Week: SciX 2024, Environmental Analysis, Advancing Forensic Science
October 25th 2024Top articles published this week include insights into machine learning and chemometrics presented at the SciX Conference, a compilation of recent studies in environmental analysis, and a news article highlighting the latest research in mineral classification.
Emerging Leader Highlights Innovations in Machine Learning, Chemometrics at SciX Awards Session
October 23rd 2024Five invited speakers joined Joseph Smith, the 2024 Emerging Leader in Molecular Spectroscopy, on stage to speak about trends in hyperspectral imaging, FT-IR, surface enhanced Raman spectroscopy (SERS), and more during the conference in Raleigh.